?2-Adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium
- 1 April 1987
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 335 (4) , 403-411
- https://doi.org/10.1007/bf00165555
Abstract
Experiments were designed to unravel the relative contribution of β1- and β2-adrenoceptors to the positive inotropic effects of adrenaline and noradrenaline in isolated tissues of left ventricular myocardium of man. We also analyzed relationships between the fractions of human left ventricular β1- and β2-adrenoceptors, estimated from binding assays, and stimulation of adenylate cyclase and contractile force by adrenaline and noradrenaline. 1) Selective blockade of β2-adrenoceptors by erythro(±)-(α-methyl-indan-4-yloxy)-3-isopropylaminobutan-2-ol (ICI 118,551) attenuated the increase of contractile force caused by adrenaline but not by noradrenaline, suggesting some involvement of β2-adrenoceptors. Selective blockade of β2-adrenoceptors without affecting α1-adrenoceptors still enabled both adrenaline and noradrenaline to cause maximum possible increases of contractile force through β1-adrenoceptors. 2) A direct involvement of β2-adrenoceptors became manifest by selectively antagonizing β1-adrenoceptors by 1-[2((3-carbamoyl-4-hydroxy)phenoxy)ethylamino]3-[4(1-methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol (CGP 20712 A) without affecting β2-adrenoceptor. β2-adrenoceptors can mediate half of the maximum increase of contractile force elicited by low concentrations of adrenaline and also contribute to the increase of contractile force caused by high concentrations of noradrenaline. 3) β-adrenoceptors were labelled in membrane particles with 3H-(−)-bupranolol in the absence (β1 & β2) and presence of 500 nmol/l CGP 20712 A (β2). 71 % of the β-adrenoceptors Were β1 and 29% β2. Binding inhibition experiments with CGP 20712 A and ICI 118,551 yielded 74% β1 and 26% β2-4) With the help of ICI 118,551 and CGP 20712 A it was found that, in membrane particles, 33–36% and 64–67% of maximum stimulation of the adenylate cyclase by noradrenaline was mediated through β1- and β2-adrenoceptors, respectively. Adrenaline caused 11–25% and 75–89% of maximum cyclase stimulation through β1- and β2-adrenoceptors, respectively. 5) The contribution of β1- and β2-adrenoceptors to the positive inotropic effects of adrenaline and noradrenaline cannot be inferred straightforwardly from biochemical estimates of receptor fractions and fractional adenylate cyclase stimulation.Keywords
This publication has 36 references indexed in Scilit:
- Beta2 receptors on myocardial cells in human ventricular myocardiumThe American Journal of Cardiology, 1986
- Contamination of a cardiac sarcolemmal preparation with endothelial plasma membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- Hypertrophic cardiomyopathy characterised by -adrenoceptor density, relative amount of -adrenoceptor subtypes and adenylate cyclase activityCardiovascular Research, 1985
- Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding.Circulation Research, 1983
- Human cardiac beta-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand bindingLife Sciences, 1983
- The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551)Journal of Cardiovascular Pharmacology, 1983
- Heart ß-Receptors: On the Functional Role of Heterogeneous Binding SitesJournal of Receptor Research, 1983
- Prostaglandin E1 action on sinus pacemaker and adenylyl cyclase in kitten myocardiumNature, 1974
- Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heartLife Sciences, 1972
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967